No, GLP-1 receptor agonists should not replace established antihypertensive medications
Papaetis GS, Filippou PK, Constantinidou KG, Stylianou CS (2020) Liraglutide: new perspectives for the treatment of polycystic ovary syndrome
Patients and providers should treat them as directional rather than definitive, and decisions about participating in trials or accessing investigational therapies should always involve a specialist in endocrinology or metabolic medicine.
Anti-Inflammatory and Antioxidant Effects: The peptide exhibits potent anti-inflammatory and antioxidant effects by inhibiting NF-B activation, reducing pro-inflammatory cytokines like TNF-, IL-6, and IL-1
2.1 Criteria for identifying underexplored peptide systems To operationalize this definition, peptidereceptor systems considered underexplored in this review meet several criteria
however, many people still don't fully understand precisely why inflammation lies at the root of most health concerns plaguing Americans today